How to remove Ads[1].exe

• » File
• File Details
• Overview
• Analysis

Ads[1].exe

The module Ads[1].exe has been detected as Trojan.Glupteba

Ads[1].exe is a Windows file recorded in the ThreatInfo database. It is associated with avejEge. The reported company name is eruxImAXOFO. The current detection status is Trojan.Glupteba, based on the latest analysis from 2023-10-24 23:50:27 (2 years ago).

If Ads[1].exe appears on your computer unexpectedly, treat it as suspicious. Check its location, digital signature, and recent system changes before allowing it to run. A full anti-malware scan is recommended when this file is detected as Trojan.Glupteba.

File Details

Overview

The signature on Ads[1].exe is reported as valid. A valid signature helps confirm publisher identity, but it does not automatically make the file safe if the installer was bundled, abused, or downloaded from an untrusted source.

ThreatInfo has observed Ads[1].exe in the locations listed above. Files found in temporary folders, user profile folders, startup locations, or unusual application directories should be reviewed more carefully than files installed under a known program directory.

The strongest geographic signal for this file is Spain with 100.0% of observed hits. Geographic distribution can help identify targeted campaigns, regional software bundles, or where a file is most commonly reported.

The most common operating system signal for Ads[1].exe is Windows 10 with 100.0% of observed hits. If your system differs from the common profile, check whether the file was introduced by a specific installer, archive, or removable device.

Analysis

Ads[1].exe is identified as pe for 64 systems. The subsystem is Windows GUI. PE header values are useful for triage, especially when they do not match the expected publisher, product, or release timeline.

PE section names and hashes can reveal packing, injected resources, or unusual build artifacts. Sections with uncommon names, very large raw data, or hashes that differ from a trusted copy deserve additional review.